Glyco680mg - New ingredient for glycemia management
Blood glucose emphasis.
Approximately 1 in 4 people in the Asia-Pacific region state they want to invest in improving their blood glucose levels. This highlights how consumers are continuing to take a proactive approach to health. FMCG Gurus, Diabetes Examining consumers perspectives Global Report, 2023.
Glyco680mg is a new solution to improve postprandial glycemia and reduce risk factors of metabolic disorders.
Selected compounds for glucose management.
Glyco680mg is a targeted blend of polyphenols from selected botanical extracts, green olive and blackcurrant, clinically screened for their effectiveness in managing post-prandial glycemia. This formulation includes essential minerals like zinc and chromium, complemented by a white kidney bean extract, offering alpha-amylase inhibition to support healthy blood sugar levels.
Clinically supported benefits.
Randomised, placebo-controlled study on 10 pre-diabetic subjects, 680 mg/day.
The Glyco680mg group showed a significant reduction in the glucose area under the curve (AUC) compared to the placebo group, indicating improved glucose management across postprandial condition.
BOOK YOUR INTRODUCTION MEETING
This website is intended to provide information about Fytexia’s ingredients, used in various food/dietary supplement products around the world. It is only intended for business to business and to provide information to food/dietary supplement professionals and is not designed for the general public. Statements used on this website have not been evaluated by the Food and Drug Administration or any other competent authority. Products are not intended to diagnose, treat, cure or prevent any disease.
